Stevanato group reports first quarter 2023 financial results

Piombino dese, italy--(business wire)--stevanato group s.p.a. (nyse: stvn), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the first quarter of 2023, and maintained its fiscal 2023 guidance. first quarter 2023 highlights (compared with the same period last year) first quarter revenue increased 12% to €238 million. revenue from high value solutions.
STVN Ratings Summary
STVN Quant Ranking